Cencora Inc. (COR) Stock Price Today—Real Time Charts and Quotes

Q: What's the stock price of Cencora Inc. (COR) today?

Cencora Inc. (COR) is currently trading at $319.63, with a 24h change of -0.84%. The 52-week trading range is $308.54–$325.84.

Q: What are the 52-week high and low prices for Cencora Inc. (COR)?

COR has a 52-week high of $325.84 and a 52-week low of $308.54, with the current price at $319.63.

Q: What is the price-to-earnings (P/E) ratio of Cencora Inc. (COR)? What does it indicate?

The current P/E ratio (TTM) of COR is 38.97553264799388, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the Medical - Distribution industry for a better context.

Q: What is the market cap of Cencora Inc. (COR)?

Cencora Inc. (COR) currently has a market cap of approximately $62.71B.

Q: What is the most recent quarterly earnings per share (EPS) for Cencora Inc. (COR)?

Cencora Inc. (COR)'s diluted earnings per share (Diluted EPS) is 8.367955761279793. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell Cencora Inc. (COR) now?

As of now, COR is trading at $319.63, with a P/E ratio of 38.97553264799388 and a diluted EPS of 8.367955761279793. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering Cencora Inc.'s financial reports, the outlook of the Medical - Distribution sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of Cencora Inc. (COR)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the Medical - Distribution sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy Cencora Inc. (COR) stock?

You can buy Cencora Inc. (COR) through Gate. Sign up for a Gate account and complete identity verification, then go to the Cencora Inc. trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

$319,63

-$2,74(-0,84%)

*Data last updated: 2026-04-17 13:39 (UTC+8)

As of 2026-04-17 13:39, Cencora Inc. (COR) is priced at $319,63, with a total market cap of $62,71B, a P/E ratio of 38,97, and a dividend yield of 0,71%. Today, the stock price fluctuated between $319,39 and $321,72. The current price is 0,07% above the day's low and 0,64% below the day's high, with a trading volume of 1,23M. Over the past 52 weeks, COR has traded between $308,54 to $325,84, and the current price is -1,90% away from the 52-week high.

COR Key Stats

Yesterday's Close$317,58

Market Cap$62,71B

Volume1,23M

P/E Ratio38,97

Dividend Yield (TTM)0,71%

Dividend Amount$0,60

Diluted EPS (TTM)8,36

Net Income (FY)$1,55B

Revenue (FY)$321,33B

Earnings Date2026-05-06

EPS Estimate4,81

Revenue Estimate$81,04B

Shares Outstanding197,46M

Beta (1Y)0.718

Ex-Dividend Date2026-02-13

Dividend Payment Date2026-03-02

About COR

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

SectorHealthcare

IndustryMedical - Distribution

CEORobert Mauch

HeadquartersConshohocken,PA,US

Official Websitehttps://www.cencora.com

Employees (FY)51,00K

Average Revenue (1Y)$6,30M

Net Income per Employee$30,47K

Ulteriori informazioni su Cencora Inc. (COR)

Blogs

RGFpbHkgTmV3cyB8IEdsaSBhZ2dpb3JuYW1lbnRpIGRpIEV0aGVyZXVtIERlbmN1biBwb3RyZWJiZXJvIHJpZHVycmUgbGUgY29tbWlzc2lvbmkgZGkgZ2VzdGlvbmUgYSAwOyBTaSBzb3NwZXR0YSBjaGUgVGVzbGEgYWJiaWEgYWNxdWlzdGF0byB1bHRlcmlvcmkgMS43ODkgQlRDOyBEbyBLd29uIHNhcsOgIGVzdHJhZGF0byBpbiBDb3J

TCdhZ2dpb3JuYW1lbnRvIGRpIEV0aGVyZXVtIERlbmN1biBwb3RyZWJiZSBhdmVyZSB1biBpbXBhdHRvIHNpZ25pZmljYXRpdm8gc3VsbGEgcmV0ZSBsYXllcjIgZSBwb3RyZWJiZSByaWR1cnJlIGxlIGNvbW1pc3Npb25pIGRpIHRyYWRpbmcgYSAwXyBBcmtoYW0gaGEgcmlsZXZhdG8gbGUgZGV0ZW56aW9uaSBkZWwgcG9ydGFmb2dsaW8gc3VsbG8gemlwIFRlc2xhLCBzb3NwZXR0YW5kbyBsJ2FjcXVpc3RvIGRpIDEuNzg5IEJpdGNvaW4gYWdnaXVudGl2aS4=

2024-03-08

Cencora Inc. (COR) FAQ

What's the stock price of Cencora Inc. (COR) today?

Cencora Inc. (COR) is currently trading at $319,63, with a 24h change of -0,84%. The 52-week trading range is $308,54–$325,84.

What are the 52-week high and low prices for Cencora Inc. (COR)?

What is the price-to-earnings (P/E) ratio of Cencora Inc. (COR)? What does it indicate?

What is the market cap of Cencora Inc. (COR)?

What is the most recent quarterly earnings per share (EPS) for Cencora Inc. (COR)?

Should you buy or sell Cencora Inc. (COR) now?

What factors can affect the stock price of Cencora Inc. (COR)?

How to buy Cencora Inc. (COR) stock?

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

COR

CFD

Fai trading

Cencora Inc. (COR) Latest News

2025-06-10 09:36

Union完成可信设置，为实现去信任跨链DeFi铺路

Gate News bot 消息，Union 创下零知识基础设施的新纪录，其 Groth16 可信设置仪式已结束，共收到 4,664 份已验证贡献，超越了 Manta Network 于 2023 年创下的纪录，另有 4,590 份贡献仍在等待中。这为使用简洁的有效性证明来验证共识和跨链消息奠定了加密基础。可信设置仪式对于零知识证明系统至关重要。Union 使其能够充当“区块链中的区块链”，在以太坊、Cosmos、Arbitrum、Babylon 甚至比特币的 L2 层之间提供可验证的消息传递和资产转移，而无需依赖任何中心化参与者。 Union 首席技术官 Cor Pruijs表示：“Union 的 Groth16 可信设置仪式拥有史上最大规模，这意味着它拥有最小的诚实假设。” “诚实假设”是指为了确保最终加密参数的安全，参与者必须诚实行事（即不泄露或重复使用其私有随机数）的最小数量。消息来源：Blockworks

2025-06-04 05:18

招银国际：升众安在线目标价至20.4港元稳定币前景带来估值重估空间

Gate News bot 消息，招银国际发表研究报告指，随著香港稳定币条例将于今年生效，相信首批参与金管局稳定币发行商沙盒的公司将成为香港虚拟资产资金流动的主要受惠者，并为关联公司带来业绩上升的机会。在保险方面，该行认为强劲的医疗和汽车保费带来的收入增长，以及CoR的改善将巩固利润结构。该行上调众安在线2025至27财年的每股盈测，分别至0.69、0.79及0.93元人民币，目标价由16港元调升至20.4港元，维持“买入”评级。消息来源：金十

Hot Posts su Cencora Inc. (COR)

NodeGuardian

14 ore fa

Bourgeon Capital Management LLC recently acquired a new stake in Cencora, Inc. (NYSE:COR), purchasing 8,124 shares valued at approximately $2.74 million in the fourth quarter. This move is part of broader institutional interest, with several other hedge funds and institutional investors also modifying their holdings in Cencora during the second quarter. The company has an average rating of "Moderate Buy" from analysts, with an average target price of $403.17, after some analysts increased their price objectives and upgraded their ratings.

NodeGuardian

18 ore fa

Allspring Global Investments Holdings LLC significantly increased its stake in Zurn Elkay Water Solutions Corp (NYSE:ZWS) during the fourth quarter, growing its holding by 73.7% to 130,827 shares, valued at $6.13 million. This increase occurred despite recent insider selling by the CEO and CFO, who collectively sold over $14 million worth of shares. Zurn Elkay reported strong quarterly earnings, beating analyst estimates with a 9.8% year-over-year revenue increase, and currently maintains a consensus "Hold" rating from analysts with an average price target of $51.63.

K-LinePoet

04-16 09:58

2026年3月6日，保健护理产品经销商公司Cencora（COR）成交额为4.06亿美元，在当日美股中排第330名，成交额较昨日减少32.96%，当日成交量为113.58万。 Cencora（COR）于2026年3月6日跌0.23%，报358.46美元，该股过去5个交易日跌3.68%，整个3月跌3.68%，年初至今涨6.13%，过去52周涨41.25%。 *如果公司上市时间少于52周，则52周涨跌幅为上市至今涨跌幅（同样适用于上市时间少于1个月或少于5个交易日的情况） | Cencora（COR） | 成交额/美元 | 成交额较昨日变化 | 成交量 | | --- | --- | --- | --- | | 2026年3月6日 | 4.06亿 | -32.96% | 113.58万 | | 2026年3月5日 | 6.06亿 | 109.07% | 169.57万 | | 2026年3月4日 | 2.90亿 | -33.73% | 78.62万 | | 2026年3月3日 | 4.37亿 | 19.46% | 119.08万 | | 2026年3月2日 | 3.66亿 | -29.97% | 98.38万 | Cencora于2026年2月4日发布2026财年一季报，2025年10月1日至2025年12月31日的收入为859.32亿美元，同比增长5.45%，净利润为5.66亿美元，同比增长14.67%。 Cencora, Inc.是全球最大的药品采购和分销服务公司之一，帮助医疗保健供应商以及制药和生物技术制造商改善患者获得产品加强患者护理的机会。该公司提供创新计划和服务，旨在提高药品供应链在人类和动物健康方面的效力和效率。更具体地说，该公司向位于美国和部分全球市场的各种医疗保健提供商提供全面的品牌、专业品牌和非专利药品、非处方医疗产品、家庭医疗用品和设备以及相关服务，包括急性病医院和卫生系统、独立和连锁零售药店、邮购药房、诊所、长期护理和替代地点药房、医师执业、医疗和透析诊所、兽医和其他客户。此外，公司还为医疗保健提供商和制药制造商提供各种相关服务，包括数据分析、结果研究、报销和药物咨询服务、利基优质物流服务、库存管理、药房自动化、药房管理和包装解决方案。

Prezzo Cencora Inc.

COR Key Stats

About COR

Trending